Barchart is a leading provider of market data and services to the global financial, media, and commodity industries. From our interactive charting library, through to our leading financial analysis desktops, we connect you to the content you need.
| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 15,715 unch on 04/07/16 | | 17,403 -9.70% on 03/30/16 | -1,095 (-6.51%) since 03/07/16 |
| 3-Month | 14,665 +7.16% on 02/12/16 | | 17,735 -11.39% on 02/01/16 | -1,820 (-10.38%) since 01/07/16 |
/Rollins%2C%20Inc_%20phone%20and%20website-%20by%20T_Schneider%20via%20Shutterstock.jpg)
Rollins has outperformed other consumer discretionary stocks over the past year and analysts remain moderately bullish about the stock’s prospects.
After today's jumbo rate cut from the Fed, here are three dividend stocks to bolster your portfolio.
For investors seeking momentum, iShares U.S. Home Construction ETF ITB is probably on the radar. The fund just hit a 52-week high and is up 77.45% from its 52-week low price of $71.22/share.But are more...
Could this be the resurgence Intel (INTC) shareholders have been looking for? A couple of back-to-back bangers for Intel with two huge announcements. Over the weekend, it was the announcement of a $3 billion...
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down by -0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.45%....
Why Casella Waste Systems (CWST) Stock Is Trading Lower Today
One of the magnificent 7 stocks, Microsoft Corporation MSFT, is part of the $3 trillion club as its shares have seen an impressive run over the past few years. However, after hitting a record high on July...
Concerns over China’s economic challenges remain rife as the year 2024 reaches its final three months. In recent years, investing in Chinese stocks has proven extremely challenging for bullish investors....
Merck MRK announced that a phase study evaluating its Daiichi Sankyo-partnered HER3-directed DXd antibody drug conjugate (ADC), patritumab deruxtecan, for treating EGFR-mutated non-small cell lung cancer...
Carter's Inc. CRI has shown a steady growth in recent times, with its stock price increasing by 10.5% in just a month. This rise is attributed to the launch of its "More Than Just Cute" back-to-school...
| Symbol | Last | Change |
|---|---|---|
| HQJ16 | 15,715s | -15 |
| SGX Nikkei Mini 225 Apr '16 | ||
| HQV24 | 36,150s | +215 |
| SGX Nikkei Mini 225 | ||
| ESZ24 | 5,694.75 | +14.75 |
| S&P 500 E-Mini | ||
| NQZ24 | 19,651.00 | +70.50 |
| Nasdaq 100 E-Mini | ||
| YMZ24 | 41,976 | +67 |
| Dow Futures Mini | ||
| QRZ24 | 2,235.50 | +5.60 |
| Russell 2000 E-Mini | ||
| EWZ24 | 3,112.40 | +8.60 |
| S&P Midcap E-Mini | ||
| ETZ24 | 5,695.00 | +15.00 |
| S&P 500 Micro | ||
| NMZ24 | 19,650.50 | +70.00 |
| Nasdaq 100 Micro | ||
| VIV24 | 18.8000 | +0.0607 |
| S&P 500 VIX | ||
| GDV24 | 527.95s | +0.45 |
| S&P GSCI | ||
| AHZ24 | 97.12s | +0.10 |
| Bloom Commodity Index | ||
| 3rd Resistance Point | N/A |
| 2nd Resistance Point | 15,715 |
| 1st Resistance Point | 15,715 |
| Last Price | 15,715s |
| 1st Support Level | 15,715 |
| 2nd Support Level | 15,715 |
| 3rd Support Level | N/A |
| 52-Week High | 19,860 |
| Fibonacci 61.8% | 17,876 |
| Fibonacci 50% | 17,263 |
| Fibonacci 38.2% | 16,649 |
| Last Price | 15,715s |
| 52-Week Low | 14,665 |
